AbCellera Biologics Inc.
Project Peregrine: Building and Accelerating Antibody Drug Development Capabilities in Canada — This project builds capabilities for therapeutic antibody development, fortifies early-phase clinical research infrastructure, advances biotech IP for the health and economic benefit of Canadians and enables rapid response to future pandemics.